Biography
Biography: Ron Ribitzky
Abstract
The Total Addressable Market (TAM) for Precision Medicine is on a trajectory of 10%+ CAGR to surpass $100B around 2025 as patient demand is on the rise, the cost of human genome sequencing continues to go down, AI happens deep inside the chip, blockchain is heading everywhere, and medical devices are just about to switch channel to IoT chat. Yet, it still takes 10+ years for basic science discovery to make a difference in the life of the first consumer it was intended for. In this session, we will re-examine the ever-elusive Precision Medicine Paradox, white space R&D, healthcare in disruption, and We the Consumers.